Remove Copying Remove Litigation Remove Marketing Remove Workshop
article thumbnail

Transatlantic Dialogue Workshop, Institute for Information Law (IViR), Amsterdam Law School Part 5: Beyond the DSA

43(B)log

Senftleben: use of collecting societies/levies can be a better regulatory answer than a cascade of opt-out and then a transparency rule to control whether opt-out is honored and then litigation on whether it’s sufficiently explained. Van Hoboken: May need new speech doctrines for, e.g., incorporating generative AI into political speech.

Law 60
article thumbnail

2021 Trade Secrets Webinar Series: Takeaways & Recordings

Trading Secrets

It is only by keeping up with the newest laws and court pronouncements that litigants can hope to prevail in this ever-changing landscape. Legislation such as anti-SLAPP laws can have a dramatic impact on a litigant’s ability to bring or defend a claim. It recently held a workshop where academics and regulators addressed the issue.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2021 Trade Secrets Webinar Series: Takeaways & Recordings

LexBlog IP

It is only by keeping up with the newest laws and court pronouncements that litigants can hope to prevail in this ever-changing landscape. Legislation such as anti-SLAPP laws can have a dramatic impact on a litigant’s ability to bring or defend a claim. It recently held a workshop where academics and regulators addressed the issue.

article thumbnail

2022 Trade Secrets Webinar Series: Takeaways & Recordings

Trading Secrets

Additionally, a recent Third Circuit decision held that copying is not the only method that trade secret plaintiffs can demonstrate actionable “use” under the Defend Trade Secrets Act. An analysis of the pros and cons of each set of rules should be part of any relevant litigation strategy. Code Section 15.50(a). View the Recording.

article thumbnail

Spicy IP Weekly Review (November 16- November 21)

SpicyIP

We informed our reader about a workshop on ‘Patent Oppositions in the Pharmaceutical Field’ organized by IUCIPRS, CUSAT, and Third World Network from December 4- 8, 2022 in Kochi, Kerala. It is worth noting that the above order was passed, despite the Defendant’s plea that it has not received any copy of the Plaint and other documents.

IP 100
article thumbnail

2022 Trade Secrets Webinar Series: Takeaways & Recordings

LexBlog IP

Additionally, a recent Third Circuit decision held that copying is not the only method that trade secret plaintiffs can demonstrate actionable “use” under the Defend Trade Secrets Act. An analysis of the pros and cons of each set of rules should be part of any relevant litigation strategy. Code Section 15.50(a).